Cited by 52Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlRenin-Angiotensin System Studies

Neuronal and hormonal perturbations in postural tachycardia syndrome

Open access
Mar, Philip L., Raj, Satish R.·2014·Frontiers in Physiology

Abstract

The Postural Tachycardia Syndrome (POTS) is the most common disorder seen in autonomic clinics. Cardinal hemodynamic feature of this chronic and debilitating disorder of orthostatic tolerance is an exaggerated orthostatic tachycardia (≥30 bpm increase in HR with standing) in the absence of orthostatic hypotension. There are multiple pathophysiological mechanisms that underlie POTS. Some patients with POTS have evidence of elevated sympathoneural tone. This hyperadrenergic state is likely a driver of the excessive orthostatic tachycardia. Another common pathophysiological mechanism in POTS is a hypovolemic state. Many POTS patients with a hypovolemic state have been found to have a perturbed renin-angiotensin-aldosterone profile. These include inappropriately low plasma renin activity and aldosterone levels with resultant inadequate renal sodium retention. Some POTS patients have also been found to have elevated plasma angiotensin II (Ang-II) levels, with some studies suggesting problems with decreased angiotensin converting enzyme 2 activity and decreased Ang-II degradation. An understanding of these pathophysiological mechanisms in POTS may lead to more rational treatment approaches that derive from these pathophysiological mechanisms.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphys.2014.00220

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some POTS patients have inappropriately low plasma renin activity and aldosterone levels resulting in inadequate renal sodium retention.

    “Some have inappropriately low plasma renin activity and aldosterone levels resulting in inadequate renal sodium retention (42,44).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [44]

  • Others have elevated plasma angiotensin II levels suggesting inadequate angiotensin-converting enzyme 2 activity.

    “Others have elevated plasma angiotensin II levels suggesting inadequate angiotensin-converting enzyme 2 activity (42,44).”

    From Postural Orthostatic Tachycardia Syndrome (2019) · cites this paper as [44]

  • Many POTS patients have a blood volume lower than expected for their size and sex, suggesting that hypovolemia may underlie some of the hemodynamic findings of POTS.

    “Many POTS patients have a blood volume that is lower than expected for their size and sex, suggesting that hypovolemia may underlie some of the hemodynamic findings of POTS (Fu et al., 2010; Mar and Raj, 2014; Raj et al., 2005).”
  • Acute infusions of normal saline afford rapid relief in patients with POTS crisis.

    “Acute infusions of normal saline have been shown to afford rapid relief in patients with POTS crisis (8, 54)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. Bonyhay, I., and Freeman, R. (2004). Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation 110, 3193-3198. doi: 10.1161/01.CIR.0000147280.90339. · DOI
  2. Chappell, M. C. (2007). Emerging evidence for a functional angiotensin- converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 50, 596-599. doi: 10.1161/HYPERTENSIONAHA.106.076216 · DOI
  3. Diedrich, A., and Biaggioni, I. (2004). Segmental orthostatic fluid shifts. Clin. Auton. Res. 14, 146-147. doi: 10.1007/s10286-004-0188-9 · DOI · Paper page
  4. Freeman, R. (2008). Clinical practice. Neurogenic orthostatic hypotension. N. Engl. J. Med. 358, 615-624. doi: 10.1056/NEJMcp074189 · DOI · Paper page
  5. Freitas, J., Santos, R., Azevedo, E., Costa, O., Carvalho, M., and de Freitas, A. F. (2000). Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin. Auton. Res. 10, 293-299. doi: 10.1007/BF02281112 · DOI · Paper page
  6. Fu, Q., Vangundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., and Levine, B. D. (2010). Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension 56, 82-90. doi: 10.1161/HYPERTENSIONAHA.110.151787 · DOI · Paper page
  7. Garland, E. M., Raj, S. R., Black, B. K., Harris, P. A., and Robertson, D. (2007). The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 69, 790-798. doi: 10.1212/01.wnl.0000267663.05398. · DOI
  8. Hoeldtke, R. D., Bryner, K. D., Hoeldtke, M. E., and Hobbs, G. (2006). Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine. Clin. Auton. Res. 16, 390-395. doi: 10.1007/s10286-006-0373-0 · DOI · Paper page
  9. Hunyady, L., and Catt, K. J. (2006). Pleiotropic AT1 receptor signaling path- ways mediating physiological and pathogenic actions of angiotensin II. Mol. Endocrinol. 20, 953-970. doi: 10.1210/me.2004-0536 · DOI · Paper page
  10. Kanjwal, K., Saeed, B., Karabin, B., Kanjwal, Y., Sheikh, M., and Grubb, B. P. (2012). Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. Am. J. Ther. 19, 92-95. doi: 10.1097/MJT. · DOI
  11. Lai, C. C., Fischer, P. R., Brands, C. K., Fisher, J. L., Porter, C. B., Driscoll, S. W., et al. (2009). Outcomes in adolescents with postural orthostatic tachycardia syn- drome treated with midodrine and beta-blockers. Pacing Clin. Electrophysiol. 32, 234-238. doi: 10.1111/j.1540-8159.2008.02207.x · DOI · Paper page
  12. Mar, P. L., Raj, V., Black, B. K., Biaggioni, I., Shibao, C. A., Paranjape, S. Y., et al. (2014). Acute hemodynamic effects of a selective serotonin reuptake inhibitor in postural tachycardia syndrome: a randomized, crossover trial. J. Psychopharmacol. 28, 155-161. doi: 10.1177/0269881113512911 · DOI · Paper page
  13. Masuki, S., Eisenach, J. H., Schrage, W. G., Johnson, C. P., Dietz, N. M., Wilkins, B. W., et al. (2007). Reduced stroke volume during exercise in postural tachy- cardia syndrome. J. Appl. Physiol. 103, 1128-1135. doi: 10.1152/japplphys- iol.00175.2007 · DOI
  14. Mustafa, H. I., Garland, E. M., Biaggioni, I., Black, B. K., Dupont, W. D., Robertson, D., et al. (2011). Abnormalities of angiotensin regulation in postu- ral tachycardia syndrome. Heart Rhythm 8, 422-428. doi: 10.1016/j.hrthm.2010. 11.009 · DOI · Paper page
  15. Mustafa, H. I., Raj, S. R., Diedrich, A., Black, B. K., Paranjape, S. Y., Dupont, W. D., et al. (2012). Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome. Circ. Arrhythm. Electrophysiol. 5, 173-180. doi: 10.1161/CIRCEP.111.965343 · DOI · Paper page
  16. Ocon, A. J., Medow, M. S., Taneja, I., Clarke, D., and Stewart, J. M. (2009). Decreased upright cerebral blood flow and cerebral autoregulation in normo- capnic postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 297, H664-H673. doi: 10.1152/ajpheart.00138.2009 · DOI · Paper page
  17. Ross, A. J., Ocon, A. J., Medow, M. S., and Stewart, J. M. (2014). A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neu- ropathic compared with hyperadrenergic postural tachycardia syndrome. Clin. Sci. (Lond). 126, 289-296. doi: 10.1042/CS20130222 · DOI · Paper page
  18. Shores, M. M., Pascualy, M., Lewis, N. L., Flatness, D., and Veith, R. C. (2001). Short-term sertraline treatment suppresses sympathetic nervous system activ- ity in healthy human subjects. Psychoneuroendocrinology 26, 433-439. doi: 10.1016/S0306-4530(01)00002-6 · DOI
  19. Singer, W., Opfer-Gehrking, T. L., Nickander, K. K., Hines, S. M., and Low, P. A. (2006). Acetylcholinesterase inhibition in patients with orthostatic intolerance. J. Clin. Neurophysiol. 23, 476-481. doi: 10.1097/01.wnp.0000229946.01494. · DOI
  20. Stewart, J. M. (2002). Pooling in chronic orthostatic intolerance: arterial vasocon- strictive but not venous compliance defects. Circulation 105, 2274-2281. doi: 10.1161/01.CIR.0000016348.55378. · DOI
  21. Stewart, J. M., Medow, M. S., and Montgomery, L. D. (2003). Local vascular responses affecting blood flow in postural tachycardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 285, H2749-H2756. doi: 10.1152/ajpheart.00429.2003 · DOI · Paper page
  22. Stewart, J. M., Taneja, I., Glover, J., and Medow, M. S. (2008). Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachy- cardia syndrome. Am. J. Physiol. Heart Circ. Physiol. 294, H466-H473. doi: 10.1152/ajpheart.01139.2007 · DOI
  23. Stewart, J. M., Taneja, I., and Medow, M. S. (2007). Reduced body mass index is associated with increased angiotensin II in young women with postu- ral tachycardia syndrome. Clin. Sci. (Lond). 113, 449-457. doi: 10.1042/ CS20070104 · DOI
  24. Vincent, S., Bieck, P. R., Garland, E. M., Loghin, C., Bymaster, F. P., Black, B. K., et al. (2004). Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation 109, 3202-3207. doi: 10.1161/01.CIR.0000130847.18666. · DOI
  25. Zhuo, J. L., and Li, X. C. (2011). New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 32, 1551-1565. doi: 10.1016/j.peptides.2011.05.012 · DOI

Cited by

Sorted by citations

Authors
Mar, P. L., & Raj, S. R.
Affiliations
Vanderbilt University (US)
Corresponding author
Raj, Satish R.
Venue
Frontiers in Physiology
Published
2014-06-16
Volume
5
Pages
220-220
ISSN
1664-042X (ISSN-L)
OpenAlex
W2052352944
Cited by
52
References
31
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 9 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 1
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Physiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
postural orthostatic tachycardia syndrome, orthostatic intolerance, orthostatic tachycardia, hyperadrenergic state, hypovolemia, renin-angiotensin-aldosterone system, plasma renin activity, aldosterone, angiotensin II, angiotensin-converting enzyme 2, renal sodium retention, autonomic dysfunction, pathophysiology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review